Dr. Louis R. ManaraOctober 21, 2021

FDA 483 - Dr. Louis R. Manara - October 21, 2021

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dr. Louis R. Manara

Record Details

An FDA inspection of Dr. Louis R. Manara, a human tissue reproductive establishment in Voorhees, NJ, revealed a significant deficiency in donor screening. The firm failed to test anonymous oocyte donors for relevant communicable disease agents, specifically West Nile Virus, before deeming them eligible to donate. This indicates a serious lapse in ensuring donor safety and compliance with regulations for human tissue products.

Company: Dr. Louis R. Manara
Inspection Date: October 21, 2021
Product Type: Biologics
Office: Philadelphia District Office
Person: Kish Bolden

Open in Dashboard

ID · 3b7ec250-afbe-4f93-b4ab-cd35e325cafb